When Will Canadian Cannabis Stocks Rebound?

Canadian marijuana companies such as Canopy Growth Corp. (TSX:WEED) have felt the exuberance of the marijuana momentum trade, but they’re now feeling the pain of valuations coming back down to earth.

| More on:

A question many investors or potential investors in Canadian cannabis companies have is, How long with this slide continue?

In short, it is hard to call the bottom on this decline as, in my opinion, what we are seeing right now is a relatively soft landing for a valuation bubble that has burst. Since November of last year, when valuations skyrocketed (with the likes of Canopy Growth Corp. (TSX:WEED) achieving a market capitalization of more than $2 billion), investors have watched as valuations in the cannabis industry have (finally) started to come back down to earth.

The industry-wide decline may be indicative of the unreasonable industry growth expectations and valuations built on these expectations, as well as grossly over-inflated expectations of a potential market size which many experts do not believe to be feasible.

Or the decline may be due to political uncertainty, lowered growth expectations for exports, or indications that regulation and taxation on Canadian cannabis companies will eventually eat up too much of the potential profitability of the industry.

Perhaps the decline is due to the evolving competitive fundamentals of the marijuana industry, one which has become incredibly competitive and consolidated, even though the commodity has not yet been officially legalized.

Whatever the case may be, the reality for investors looking at the marijuana industry as a whole is that the market now appears to be finding an equilibrium with the smart money standing up and voicing an opinion — one which appears to be bearish.

Bearish analyst outlooks on the marijuana industry have been propagating of late. Chris Damas of BCMI Research was one of the first to publicly denounce the bullish sentiment last year, inviting investors to take a look at the data with respect to the total expected Canadian cannabis market with a critical lens. Mr. Damas’s research points out that current estimates for the supply and demand of marijuana in post-legalization Canada have suggested that a supply glut is likely to impact the profit margins of Canadian producers, at least initially.

With the first ever publicly traded exchange traded fund (ETF) now on the TSX trading as Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ) seeing a 17% drop since its IPO in April, despite a huge amount of interest initially, those investors who chose to buy into the bullish short-term momentum-related sentiment which drove the Canadian marijuana sector to ever-increasing highs are now feeling the pain of the market correcting the over-valuations.

Stay Foolish, my friends.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »